Source link : https://www.newshealth.biz/health-news/psoriasis-control-maintained-long-term-with-extended-dosing-interval-of-guselkumab/
Response-guided maintenance treatment for psoriasis allowed patients with exceptional early responses to double the treatment interval with guselkumab (Tremfya) with no loss in disease control, a randomized trial showed. More than 90% of patients had a psoriasis area and severity index (PASI) score
Author : News Health
Publish date : 2024-08-05 21:42:10
Copyright for syndicated content belongs to the linked Source.